PharmaShots | Incisive News in 3 Shots

Subscribe Now

Severe Asthma

Sanofi's Dupixent (dupilumab) Receives NICE Recommendation for the Treatment of Severe Asthma

Sanofi's Dupixent (dupilumab) Receives NICE Recommendation for the Treatment of Severe Asthma

October 19, 2021

AstraZeneca and Amgen Present Results of Tezepelumab in P-III NAVIGATOR Study for Severe Asthma at ATS2021

AstraZeneca and Amgen Present Results of Tezepelumab in P-III NAVIGATOR Study for Severe Asthma at ATS2021

May 13, 2021

AstraZeneca and Amgen Submit BLA to US FDA for Tezepelumab to Treat Severe Asthma

AstraZeneca and Amgen Submit BLA to US FDA for Tezepelumab to Treat Severe Asthma

May 11, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us